Hormone Health Hub: Expert Insights on Testing, Balance & Better Living — women’s endocrine wellness

In perimenopause, falling estradiol doesn’t just trigger hot flashes — it disrupts serotonin production, driving mood swings, brain fog and sleepless nights. Discover the hormonal science behind “the change” and how testing can help.

Breast cancer is not one disease — it encompasses many distinct types with different attributes, degrees of invasiveness and treatment responses. Understanding the difference between invasive and non-invasive cancers, what hormone receptor status means, and which risk factors are modifiable can help women make more informed decisions about screening, lifestyle and hormone health. This article provides a clear, evidence-based overview.

Breast cancer rates have risen from 1 in 30 to 1 in 8 women over the past 30 years — yet the focus remains on treatment rather than prevention. Drawing on 35 years of clinical experience and infrared thermography, this article makes the case that environmental toxins, xenoestrogens, hormone imbalance and lifestyle factors may account for 91–93% of breast cancer risk. Prevention, not just awareness, is the real cure.

When sex hormone test results show both oestradiol (E2) and progesterone (Pg) within normal ranges, yet symptoms persist, the Pg/E2 ratio provides a critical additional layer of clinical insight. A low ratio points to oestrogen dominance; a high ratio to progesterone dominance — each requiring a different therapeutic response. This article explains how the ratio is calculated, when it is clinically relevant, and how a real-world case illustrates its practical value.

Estrogen dominance — an excess of oestrogen relative to progesterone — is one of the most common hormonal imbalances in women. From heavy periods and mood swings to breast tenderness and weight gain, the symptoms are wide-ranging. Discover the causes, what to test, and how to restore balance.